Hikma Pharmaceuticals (HKMPF) Short Interest Ratio & Short Volume → The #1 Crypto That You Don’t Own… Yet (From Crypto 101 Media) (Ad) Free HKMPF Stock Alerts $25.25 +0.33 (+1.30%) (As of 06/4/2024) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartDividendHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartDividendHeadlinesShort Interest Hikma Pharmaceuticals Short Interest DataCurrent Short Interest1,863,300 sharesPrevious Short Interest1,849,700 sharesChange Vs. Previous Month+0.74%Dollar Volume Sold Short$45.65 millionShort Interest Ratio6,211.0 Days to CoverLast Record DateMay 15, 2024Outstanding Shares220,230,000 sharesPercentage of Shares Shorted0.85%Today's Trading Volume200 sharesAverage Trading Volume616 sharesToday's Volume Vs. Average32% Short Selling Hikma Pharmaceuticals ? Sign up to receive the latest short interest report for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHKMPF Short Interest Over TimeHKMPF Days to Cover Over TimeHKMPF Percentage of Float Shorted Over Time Ad Smallcaps DailyIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closelyLearn how this American company is leading the lithium-ion revolution Hikma Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20241,863,300 shares $45.65 million +0.7%N/A6211 $24.50 4/30/20241,849,700 shares $41.30 million +6.2%N/A9248.5 $22.33 4/15/20241,741,900 shares $42.24 million 0.0%N/A5806.3 $24.25 3/31/20241,742,100 shares $40.71 million +0.2%N/A8710.5 $23.37 3/15/20241,739,000 shares $40.64 million 0.0%N/A8695 $23.37 2/29/20241,739,100 shares $46.09 million +0.1%N/A5797 $26.50 Get the Latest News and Ratings for HKMPF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/20241,737,700 shares $43.44 million -1.2%N/A2172.1 $25.00 1/15/20241,756,000 shares $43.30 million No ChangeN/A8780 $24.66 12/31/20231,756,000 shares $40.01 million -10.0%N/A2676.8 $22.79 12/15/20231,951,100 shares $43.02 million +0.1%N/A19511 $22.05 11/30/20231,948,900 shares $42.95 million +0.3%N/A721.8 $22.04 11/15/20231,944,100 shares $43.28 million +0.5%N/A4860.3 $22.26 10/31/20231,934,300 shares $45.24 million +4.5%N/A4835.8 $23.39 10/15/20231,850,400 shares $46.97 million +5.5%N/A9252 $25.38 9/30/20231,754,100 shares $47.36 million -1.1%N/A17541 $27.00 9/15/20231,774,300 shares $47.91 million -0.1%N/A17743 $27.00 8/31/20231,775,300 shares $47.93 million +0.1%N/A1894.6 $27.00 8/15/20231,774,500 shares $46.94 million +0.1%N/A4436.3 $26.45 7/31/20231,773,300 shares $46.90 million +13.1%N/A479.3 $26.45 7/15/20231,567,500 shares $36.24 million 0.0%N/A1045 $23.12 6/30/20231,567,700 shares $36.21 million -8.0%N/A7838.5 $23.10 6/15/20231,703,900 shares $40.89 million +0.4%N/A8519.5 $24.00 5/31/20231,697,100 shares $39.03 million -0.3%N/A5657 $23.00 5/15/20231,702,000 shares $38.96 million -0.7%N/A17020 $22.89 4/30/20231,714,200 shares $39.72 million +0.4%N/A2857 $23.17 4/15/20231,707,400 shares $35.24 million +11.9%N/A17074 $20.64 3/31/20231,526,500 shares $30.94 million -2.7%N/A1908.1 $20.27 3/15/20231,569,000 shares $32.38 million -0.2%N/A2241.4 $20.64 2/28/20231,571,400 shares $33.20 million +0.3%N/A3928.5 $21.13 2/15/20231,567,000 shares $32.67 million -0.9%N/A3134 $20.85 1/31/20231,580,400 shares $29.82 million +0.6%N/A0 $18.87 1/15/20231,571,500 shares $29.65 million -0.6%N/A0 $18.87 12/30/20221,581,500 shares $29.84 million +0.0%N/A3953.8 $18.87 12/15/20221,581,200 shares $29.84 million -0.1%N/A15812 $18.87 11/30/20221,582,800 shares $22.62 million -0.3%N/A3165.6 $14.29 11/15/20221,588,000 shares $22.69 million +0.3%N/A15880 $14.29 10/31/20221,582,900 shares $22.62 million +0.2%N/A3165.8 $14.29 10/15/20221,579,400 shares $22.55 million +0.4%N/A493.6 $14.28 9/30/20221,572,800 shares $21.64 million +0.2%N/A1966 $13.76 9/15/20221,569,100 shares $23.32 million +114.5%N/A412.9 $14.86You won't believe what Citigroup just did to it's depositors (Ad)The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW 8/31/2022731,700 shares $10.87 million No ChangeN/A385.1 $14.86 8/15/2022731,700 shares $14.20 million +0.5%N/A7317 $19.41 7/31/2022727,800 shares $14.62 million +0.5%N/A7278 $20.09 7/15/2022724,400 shares $14.22 million +54.8%N/A2414.7 $19.63 6/30/2022468,100 shares $8.51 million +0.3%N/A173.4 $18.19 6/15/2022466,700 shares $9.72 million +16.2%N/A4667 $20.82 5/31/2022401,700 shares $8.36 million +3,454.9%N/A0 $20.82 5/15/202211,300 shares $235,266.00 -86.6%N/A4.7 $20.82 4/30/202284,600 shares $2.37 million -1.7%N/A282 $28.00 4/15/202286,100 shares $2.41 million -1.3%N/A861 $28.00 3/31/202287,200 shares $2.44 million +87.1%N/A79.3 $28.00 3/15/202246,600 shares $1.13 million +639.7%N/A66.6 $24.30 2/28/20226,300 shares $176,400.00 -19.2%N/A21 $28.00 2/15/20227,800 shares $210,600.00 -41.8%N/A78 $27.00 1/31/202213,400 shares $361,130.00 -1.5%N/A33.5 $26.95 1/15/202213,600 shares $384,200.00 -26.5%N/A34 $28.25 12/31/202118,500 shares $529,840.00 -66.5%N/A46.3 $28.64 12/15/202155,200 shares $1.60 million +1,477.1%N/A276 $28.92 11/30/20213,500 shares $112,000.00 +169.2%N/A35 $32.00 11/15/20211,300 shares $41,600.00 +44.4%N/A13 $32.00 10/29/2021900 shares $28,800.00 -35.7%N/A9 $32.00 10/15/20211,400 shares $44,800.00 +7.7%N/A14 $32.00 9/30/20211,300 shares $44,525.00 -23.5%N/A13 $34.25 9/15/20211,700 shares $58,310.00 -97.8%N/A17 $34.30 8/31/202177,600 shares $2.66 million -72.7%N/A388 $34.30 8/13/2021284,000 shares $9.94 million -13.2%N/A946.7 $35.00 7/30/2021327,200 shares $11.99 million -11.1%N/A218.1 $36.65 7/15/2021368,000 shares $12.69 million -31.2%N/A613.3 $34.49 6/30/2021534,900 shares $17.65 million +1.5%N/A2674.5 $33.00 6/15/2021526,900 shares $18.05 million +11.8%N/A50.7 $34.25 5/28/2021471,200 shares $16.44 million -11.3%N/A785.3 $34.90 5/14/2021530,900 shares $17.20 million +1.9%N/A1327.3 $32.39 4/30/2021520,800 shares $17.37 million +71.7%N/A1041.6 $33.35 4/15/2021303,400 shares $10.01 million -19.7%N/A505.7 $33.00 3/31/2021377,700 shares $11.65 million -26.6%N/A1259 $30.85 3/15/2021514,700 shares $16.32 million +3.1%N/A735.3 $31.70 2/26/2021499,200 shares $16.27 million -0.8%N/A1664 $32.60 2/12/2021503,000 shares $16.10 million +90.2%N/A628.8 $32.00 1/29/2021264,500 shares $9.06 million +3.1%N/A661.3 $34.25 1/15/2021248,500 shares $8.80 million +5.2%N/A1242.5 $35.40 12/31/2020248,500 shares $8.54 million No ChangeN/A2485 $34.38 12/15/2020248,500 shares $8.41 million +5.2%N/A1242.5 $33.85 11/30/2020236,300 shares $8.24 million -0.5%N/A94.5 $34.86 11/15/2020237,500 shares $8.13 million +1.8%N/A593.8 $34.23 10/30/2020233,400 shares $7.92 million -20.9%N/A1167 $33.93 10/15/2020295,100 shares $10.33 million -0.5%N/A491.8 $35.00 9/30/2020296,700 shares $9.71 million +0.7%N/A185.4 $32.73 9/15/2020294,700 shares $10.17 million -9.6%N/A50.8 $34.50 8/31/2020326,000 shares $10.17 million -41.6%N/A296.4 $31.19 8/14/2020558,500 shares $16.25 million +16.6%N/A797.9 $29.10You won't believe what Citigroup just did to it's depositors (Ad)The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW 7/31/2020479,200 shares $13.23 million +2.6%N/A1597.3 $27.60 7/15/2020467,000 shares $12.38 million +5.7%N/A311.3 $26.50 6/30/2020441,900 shares $12.15 million -13.4%N/A192.1 $27.50 6/15/2020510,300 shares $14.29 million -4.6%N/A2551.5 $28.00 5/29/2020535,100 shares $17.12 million -4.7%N/A594.6 $32.00 5/15/2020561,500 shares $16.79 million -9.1%N/A467.9 $29.90 4/30/2020617,700 shares $18.53 million -2.5%N/A166.9 $30.00 4/15/2020633,700 shares $18.03 million +11.9%N/A81.2 $28.45 3/31/2020566,400 shares $16.09 million +4.6%N/A145.2 $28.40 3/13/2020541,300 shares $14.56 million -4.4%N/A902.2 $26.90 2/28/2020566,200 shares $13.82 million +5.8%N/A5662 $24.40 2/14/2020535,000 shares $13.11 million +12.9%N/A1783.3 $24.50 1/31/2020473,700 shares $11.56 million +4.3%N/A128 $24.40 1/15/2020454,400 shares $10.45 million +2.2%N/A4544 $23.00 12/31/2019444,500 shares $10.22 million +19.9%N/A4445 $23.00 HKMPF Short Interest - Frequently Asked Questions What is Hikma Pharmaceuticals' current short interest? Short interest is the volume of Hikma Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 1,863,300 shares of HKMPF short. Learn More on Hikma Pharmaceuticals' current short interest. What is a good short interest ratio for Hikma Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HKMPF shares currently have a short interest ratio of 6,211.0. Learn More on Hikma Pharmaceuticals's short interest ratio. Is Hikma Pharmaceuticals' short interest increasing or decreasing? Hikma Pharmaceuticals saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 1,863,300 shares, an increase of 0.7% from the previous total of 1,849,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Hikma Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "private households" compare to Hikma Pharmaceuticals: Central Japan Railway (0.00%), Sampo Oyj (0.00%), Sompo Holdings, Inc. (0.00%), Commerzbank AG (0.00%), Sands China Ltd. (0.00%), Ajinomoto Co., Inc. (0.00%), CK Hutchison Holdings Limited (0.00%), Grupo Financiero Inbursa, S.A.B. de C.V. (0.00%), SGS SA (0.00%), Davide Campari-Milano (0.47%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Hikma Pharmaceuticals stock? Short selling HKMPF is an investing strategy that aims to generate trading profit from Hikma Pharmaceuticals as its price is falling. HKMPF shares are trading up $0.33 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Hikma Pharmaceuticals? A short squeeze for Hikma Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HKMPF, which in turn drives the price of the stock up even further. How often is Hikma Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HKMPF, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: CJPRY Short Squeeze SAXPY Short Squeeze SMPNY Short Squeeze CRZBY Short Squeeze SCHYY Short Squeeze AJINY Short Squeeze CKHUY Short Squeeze GPFOY Short Squeeze SGSOY Short Squeeze DVDCF Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:HKMPF) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hikma Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Hikma Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.